Tag Archive for: Immunotherapy

ISA Pharmaceuticals long term study confirms efficacy of our T-cell activating immunotherapy in combination with checkpoint inhibitor

/in

Data published in the Journal of ImmunoTherapy of Cancer confirms efficacy of combination treatment (ISA101b + anti-PD1) Deep and durable responses have a profound positive effect on patient prognosis with patients disease-free for more than 44 months Improved tumour infiltration by immune cells predicted response to therapy Oegstgeest, March 1, 2022 – ISA today announces the publication of […]

Read more

ISA Pharmaceuticals to Attend Multiple In Person Conferences in Early 2022

/in

Oegstgeest, the Netherlands, February 17, 2022 – ISA Pharmaceuticals will be attending the following in person scientific and business conferences from February through to April 2022 (subject to travel restrictions), in addition to virtual conferences. Read more…

Read more

eTheRNA Announces Research Agreement with Merck to access mRNA technologies

/in

eTheRNA immunotherapies NV (“eTheRNA”) is pleased to announce the start of a strategic partnership with Merck with the signing of a Research Agreement. The partnership will investigate the application of eTheRNA’s proprietary mRNA design expertise and LNP-delivery platforms to disease areas selected by Merck. The ongoing pandemic has underlined the capability for mRNA vaccines as […]

Read more

eTheRNA immunotherapies conference attendance from December 2021 to March 2022

/in

eTheRNA immunotherapies NV (‘eTheRNA’), a private clinical-stage biotechnology company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, will be attending the following conferences from December 2021 to March 2022: BioFIT Digital 7-9 December 2021 Tim Van Assche, VP of Business Development and Alliance will be in attendance. ESMO Immuno-Oncology Online Congress 8-11 […]

Read more

Natural Killer Cells from Universal Donors

/in

Has Kiadis Found Immunotherapy’s Killer App? In Amsterdam, there has just been a glimpse of the future of cellular medicine.

Read more